California cannot seek damages from 23andMe successor over 2023 data breach A U.S. bankruptcy judge on Friday said California cannot seek damages from the company formerly known as 23andMe arising ...
Following in the footsteps of the other review programs at the US Food and Drug Administration's (FDA) Office of Pharmaceutical Science, the Office of Biotechnology Products (OBP) is currently in the ...
People with kidney failure experience high rates of loneliness and social isolation, yet social health remains underrecognized in care. Greater integration of social health into clinical practice, ...
Devplan, the intelligence layer for AI-native product development, is emerging from stealth along with announcing $2.5 million in seed funding, enabling the company to accelerate product development, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results